These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 15083104

  • 1. The insurance effect on prescription drug expenditures among the elderly: findings from the 1997 Medical Expenditure Panel Survey.
    Curtis LH, Law AW, Anstrom KJ, Schulman KA.
    Med Care; 2004 May; 42(5):439-46. PubMed ID: 15083104
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.
    Lillard LA, Rogowski J, Kington R.
    Med Care; 1999 Sep; 37(9):926-36. PubMed ID: 10493470
    [Abstract] [Full Text] [Related]

  • 5. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C.
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [Abstract] [Full Text] [Related]

  • 6. Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018.
    Yeung K, Dusetzina SB, Basu A.
    JAMA Netw Open; 2021 Jun 01; 4(6):e2113393. PubMed ID: 34125219
    [Abstract] [Full Text] [Related]

  • 7. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS, Miller GE.
    Med Care; 2006 May 01; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Factors associated with prescription drug expenditures among children: an analysis of the Medical Expenditure Panel survey.
    Chen AY, Chang RK.
    Pediatrics; 2002 May 01; 109(5):728-32. PubMed ID: 11986428
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW, Brook RH, Keeler E, Mangione CM.
    JAMA; 2003 Jul 09; 290(2):222-7. PubMed ID: 12851277
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Beyond survey data: a claims-based analysis of drug use and spending by the elderly.
    Steinberg EP, Gutierrez B, Momani A, Boscarino JA, Neuman P, Deverka P.
    Health Aff (Millwood); 2000 Jul 09; 19(2):198-211. PubMed ID: 10718034
    [Abstract] [Full Text] [Related]

  • 17. The impact of Medicare Part D on prescription drug use by the elderly.
    Lichtenberg FR, Sun SX.
    Health Aff (Millwood); 2007 Jul 09; 26(6):1735-44. PubMed ID: 17978393
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.
    Haas JS, Phillips KA, Gerstenberger EP, Seger AC.
    Ann Intern Med; 2005 Jun 07; 142(11):891-7. PubMed ID: 15941695
    [Abstract] [Full Text] [Related]

  • 20. Ophthalmic Medication Expenditures and Out-of-Pocket Spending: An Analysis of United States Prescriptions from 2007 through 2016.
    Chen EM, Kombo N, Teng CC, Mruthyunjaya P, Nwanyanwu K, Parikh R.
    Ophthalmology; 2020 Oct 07; 127(10):1292-1302. PubMed ID: 32359935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.